United Kingdom

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

15 Jul 2019
Change (% chg)

$-0.21 (-0.95%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Dulac, Emmanuel 

Dr. Emmanuel Dulac has been appointed Chief Executive Officer of ZEALAND PHARMA A/S effective as of April 22, 2019. He has 25 years of experience in the pharmaceutical industry, with a strong record of commercial and operational leadership underpinned by several senior roles in Europe and North America. Since August 2016, Emmanuel has been the Chief Commercial Officer at Alnylam Pharmaceuticals. He previously held leadership positions at Novartis, Abbott, Sanofi, and Shire.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --